Rheumatoid arthritis

The growing problem of antibiotic resistance isn’t slowing down, which could soon render our best drugs useless against infection. Now, an existing rheumatoid arthritis drug could be repurposed to cancel bacteria’s resistance to antibiotics.

Researchers looking for biomarkers to predict rheumatoid arthritis flare-ups have discovered a never-before-seen type of cell. Dubbed PRIME cells, they accumulate in the bloodstream seven days before a flare, but strangely disappear during the flare.

Two new imaging breakthroughs demonstrate a PET/MRI approach to locate specific locations of chronic pain in a patient, and a full-body scanner that can visualize the complete systemic burden of inflammatory arthritis for the very first time.

In a new study led by the University of Verona, researchers have used plant viruses to make new nanoparticles that show promise in mice for treating autoimmune diseases like type 1 diabetes and rheumatoid arthritis.

While there are drugs that help reduce the symptoms of rheumatoid arthritis in joints, those medications can have unpleasant side effects in other parts of the body. An experimental new light-based system, however, is being designed to change that.

Scientists have just discovered a new mechanism that can be key in regulating inflammation in sufferers of autoimmune disease, raising hopes of new drugs that can better protect against it and the ailments it can bring, such as rheumatoid arthritis.

Researchers have found a way to “reboot” the immune system, helping to treat and prevent diseases like rheumatoid arthritis and vasculitis.

In newly published research, researchers have uncovered evidence of how bacterial toxins stemming from poor oral hygiene can make their way into the brain and may well contribute to Alzheimer’s disease, and others like it. ​

Combining two cellular-editing processes, researchers have developed cartilage that fights inflammation. The scientists hope that the breakthrough could eventually lead to localized injections that combat arthritis or perhaps a vaccine that would eliminate the condition altogether.

More than one million Americans suffer from rheumatoid arthritis. Now, success in an early clinical trial suggests that a new form of therapy could stop these symptoms taking hold, by retraining the patient's immune system to ignore a particular peptide that it normally identifies as a foreign foe.